ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $9.22M

      Shares

      37.2k

      % of Portfolio

      0.16%

      Average Buy Price

      $293

      Avg closing price
      Price range

      10 Jefferies Group West Pharmaceutical Services Trades

      Jefferies Group acquired 37.2k West Pharmaceutical Services shares worth $9.22M. That's 0.16% of their equity portfolio (114th largest holding). The first West Pharmaceutical Services trade was made in Q1 2023. Since then Jefferies Group bought shares six more times and sold shares on three occasions. The investor's estimated purchase price is $10.9M, resulting in a loss of 15%.

      Avg closing price
      Price range
      Increased shares by 93.9% (+18k shares) Q2 2025
      Avg closing price $213.49
      Price range $190.39 - $227.70
      Sold 43.5% shares (-14.8k shares) Q1 2025
      Avg closing price $276.57
      Price range $199.11 - $347.87
      Increased shares by 315.9% (+25.8k shares) Q4 2024
      Avg closing price $315.45
      Price range $286.40 - $344.00
      Increased shares by 204.9% (+5.5k shares) Q3 2024
      Avg closing price $306.59
      Price range $277.16 - $333.30
      Sold 77.1% shares (-9.02k shares) Q2 2024
      Avg closing price $353.40
      Price range $314.68 - $395.94
      Increased shares by 20.7% (+2.01k shares) Q1 2024
      Avg closing price $369.91
      Price range $338.27 - $413.00
      Increased shares by 15.5% (+1.3k shares) Q4 2023
      Avg closing price $353.90
      Price range $318.29 - $392.21
      Increased shares by 191.7% (+5.52k shares) Q3 2023
      Avg closing price $386.88
      Price range $354.90 - $412.41
      Sold 40.0% shares (-1.92k shares) Q2 2023
      Avg closing price $357.24
      Price range $334.63 - $382.47
      New holding (+4.8k shares) Q1 2023
      Avg closing price $292.19
      Price range $232.50 - $346.47

      News about West Pharmaceutical Services, Inc. and Jefferies Group

      Q2 2024 EPS Estimates for West Pharmaceutical Services, Inc. (NYSE:WST) Cut by Analyst

      Q2 2024 EPS Estimates for West Pharmaceutical Services, Inc. (NYSE:WST) Cut by Analyst

      West Pharmaceutical Services, Inc. (NYSE:WST &#8211; Free Report) &#8211; Stock analysts at Zacks Research dropped their Q2 2024 earnings estimates for West ...

      https://www.defenseworld.net https://www.defenseworld.net, over 1 year ago
      TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC''s ''Final Trades''

      TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC''s ''Final Trades''

      On CNBC¡¯s " Halftime Report Final Trades ," Steve Weiss of Short Hills Capital Partners named TransDigm Group Incorporated (NYSE: TDG ), which is scheduled t...

      Benzinga Benzinga, over 1 year ago
      BofA ups West Pharmaceutical to buy, citing increased GLP-1 demand

      BofA ups West Pharmaceutical to buy, citing increased GLP-1 demand

      BofA Securities has raised its rating on West Pharmaceutical Services (WST) to buy and the price target for Stevanato Group (STVN) amid increased demand for ...

      Seeking Alpha Seeking Alpha, about 2 years ago
      West''s Ready Pack containment solution with Corning Valor RTU Vials utilizing Stevanato Group''s EZ-fill technology recognized for Best Technologies Award at INTERPHEX

      West''s Ready Pack containment solution with Corning Valor RTU Vials utilizing Stevanato Group''s EZ-fill technology recognized for Best Technologies Award at INTERPHEX

      EXTON, Pa., May 2, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administr...

      PR Newswire PR Newswire, over 2 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×